Circulating small RNA signatures differentiate accurately the subtypes of muscular dystrophies: small-RNA next-generation sequencing analytics and functional insights

References

• Emery AE. The muscular dystrophies. Lancet. 2002;359(9307):687–695.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Okuno T, Honda Y, et al. Central nervous system involvement in progressive muscular dystrophy. Arch Dis Child. 1980;55(8):589–594.
   PubMed Web of Science ®Google Scholar
• Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919–928.
   PubMed Web of Science ®Google Scholar
• Hathout Y, Seol H, Han MHJ, et al. Clinical utility of serum biomarkers in Duchenne muscular dystrophy. Clin Proteomics. 2016;13(1):9.
   PubMedGoogle Scholar
• Harper PS. Postoperative complications in myotonic dystrophy. Lancet. 1989;2(8674):1269.
   PubMed Web of Science ®Google Scholar
• Aslanidis C, Jansen G, Amemiya C, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 1992;355(6360):548–551.
   PubMed Web of Science ®Google Scholar
• Larkin K, Fardaei M. Myotonic dystrophy–a multigene disorder. Brain Res Bull. 2001;56(3–4):389–395.
   PubMed Web of Science ®Google Scholar
• Day JW, Ricker K, Jacobsen JF, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003;60(4):657–664.
   PubMed Web of Science ®Google Scholar
• Sarfarazi M, Wijmenga C, Upadhyaya M, et al. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet. 1992;51(2):396–403.
   PubMed Web of Science ®Google Scholar
• Steel D, Main M, Manzur A, et al. Clinical features of facioscapulohumeral muscular dystrophy 1 in childhood. Dev Med Child Neurol. 2019;61(8):964–971.
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Padberg GW, Moerer P, et al. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics. 1991;9(4):570–575.
   PubMed Web of Science ®Google Scholar
• Tawil R, Kissel JT, Heatwole C, et al. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology and the practice issues review panel of the American association of neuromuscular & electrodiagnostic medicine. Neurology. 2015;85(4):357–364.
   PubMedGoogle Scholar
• Wagner KR. Facioscapulohumeral Muscular Dystrophies. Continuum (Minneap Minn). 2019;25(6):1662–1681.
   PubMedGoogle Scholar
• Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle. 2014;4(1):12.
   PubMedGoogle Scholar
• de Greef JC, Lemmers RJLF, Camano P, et al. Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology. 2010;75(17):1548–1554.
   PubMed Web of Science ®Google Scholar
• Vissing J. Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies. Curr Opin Neurol. 2016;29(5):635–641.
   PubMed Web of Science ®Google Scholar
• Iyadurai SJ, Kissel JT. The limb-girdle muscular dystrophies and the dystrophinopathies. Continuum (Minneap Minn). 2016;22(6):1954–1977. Muscle and Neuromuscular Junction Disorders.
   PubMedGoogle Scholar
• Lasa-Elgarresta J, Mosqueira-Martín L, Naldaiz-Gastesi N, et al. Calcium mechanisms in limb-girdle muscular dystrophy with CAPN3 mutations. Int J Mol Sci. 2019;20(18):4548.
   PubMed Web of Science ®Google Scholar
• Pegoraro E, and Hoffman EP Limb-girdle muscular dystrophy overview - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. In: Adam MP (ed.). GeneReviews((R)). Seattle (WA): GeneReviews((R))[Internet]; 2000.
   Google Scholar
• Guiraud S, Aartsma-Rus A, Vieira NM, et al. The pathogenesis and therapy of muscular dystrophies. Annu Rev Genomics Hum Genet. 2015;16(1):281–308.
   PubMedGoogle Scholar
• Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin. 2014;32(3):729–749. ix.
   PubMed Web of Science ®Google Scholar
• Vihola A, Bassez G, Meola G, et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology. 2003;60(11):1854–1857.
   PubMed Web of Science ®Google Scholar
• Chemello F, Wang Z, Li H, et al. Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing. Proc Natl Acad Sci U S A. 2020;117(47):29691–29701.
   PubMed Web of Science ®Google Scholar
• Banerji CRS, Henderson D, Tawil RN, et al. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity. Hum Mol Genet. 2020;29(16):2746–2760.
   PubMed Web of Science ®Google Scholar
• Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381(9869):845–860.
   PubMed Web of Science ®Google Scholar
• Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005;32(1):1–18.
   PubMed Web of Science ®Google Scholar
• Lovering RM, Porter NC, Bloch RJ. The muscular dystrophies: from genes to therapies. Phys Ther. 2005;85(12):1372–1388.
   PubMed Web of Science ®Google Scholar
• Kirby TJ, Chaillou T, McCarthy JJ. The role of microRNAs in skeletal muscle health and disease. Front Biosci (Landmark Ed). 2015;20(1):37–77.
   PubMedGoogle Scholar
• Koutsoulidou A, Mastroyiannopoulos NP, Furling D, et al. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol. 2011;11(1):34.
   PubMedGoogle Scholar
• Koutalianos D, Koutsoulidou A, Mastroyiannopoulos NP, et al. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206. J Cell Sci. 2015;128(19):3631–3645.
   PubMed Web of Science ®Google Scholar
• Masi LN, Serdan TDA, Levada-Pires AC, et al. Regulation of gene expression by exercise-related micrornas. Cell Physiol Biochem. 2016;39(6):2381–2397.
   PubMedGoogle Scholar
• Hanke M, Hoefig K, Merz H, et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28(6):655–661.
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3(9):e3148.
   PubMed Web of Science ®Google Scholar
• Li LM, Hu Z-B, Zhou Z-X, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010;70(23):9798–9807.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106(11):4402–4407.
   PubMed Web of Science ®Google Scholar
• Hrach HC, Mangone M. miRNA Profiling for early detection and treatment of duchenne muscular dystrophy. Int J Mol Sci. 2019;20(18):4638.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Aloizou A-M, Siokas V, et al. The role of microRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci. 2018;66(4):617–628.
   PubMed Web of Science ®Google Scholar
• Kaifer KA, Villalón E, O’Brien BS, et al. AAV9-mediated delivery of miR-23a reduces disease severity in smn2B/-SMA model mice. Hum Mol Genet. 2019;28(19):3199–3210.
   PubMed Web of Science ®Google Scholar
• Chen TH. Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy. Ther Adv Neurol Disord. 2020;13:1756286420979954.
   Web of Science ®Google Scholar
• Koutsoulidou A, Phylactou LA. Circulating biomarkers in muscular dystrophies: disease and therapy monitoring. Mol Ther Methods Clin Dev. 2020;18:230–239.
   PubMed Web of Science ®Google Scholar
• Ambrose KK, Ishak T, Lian L-H, et al. Deregulation of microRNAs in blood and skeletal muscles of myotonic dystrophy type 1 patients. Neurol India. 2017;65(3):512–517.
   PubMed Web of Science ®Google Scholar
• Koutsoulidou A, Kyriakides TC, Papadimas GK, et al. Elevated muscle-specific miRNAs in serum of myotonic dystrophy patients relate to muscle disease progress. PLoS One. 2015;10(4):e0125341.
   PubMed Web of Science ®Google Scholar
• Matsuzaka Y, Kishi S, Aoki Y, et al. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and becker muscular dystrophy. Environ Health Prev Med. 2014;19(6):452–458.
   PubMed Web of Science ®Google Scholar
• Anaya-Segura MA, Rangel-Villalobos H, Martínez-Cortés G, et al. Serum levels of microRNA-206 and novel mini-STR assays for carrier detection in duchenne muscular dystrophy. Int J Mol Sci. 2016;17(8).
   PubMed Web of Science ®Google Scholar
• Hu J, Kong M, Ye Y, et al. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy. J Neurochem. 2014;129(5):877–883.
   PubMed Web of Science ®Google Scholar
• Perfetti A, Greco S, Bugiardini E, et al. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord. 2014;24(6):509–515.
   PubMed Web of Science ®Google Scholar
• Vignier N, Amor F, Fogel P, et al. Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One. 2013;8(2):e55281.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Nakamura A, Aoki Y, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One. 2011;6(3):e18388.
   PubMed Web of Science ®Google Scholar
• Roberts TC, Blomberg KEM, McClorey G, et al. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids. 2012;1:e39.
   PubMedGoogle Scholar
• Cacchiarelli D, Legnini I, Martone J, et al. miRNAs as serum biomarkers for duchenne muscular dystrophy. EMBO Mol Med. 2011;3(5):258–265.
   PubMed Web of Science ®Google Scholar
• Roberts TC, Godfrey C, McClorey G, et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res. 2013;41(20):9500–9513.
   PubMed Web of Science ®Google Scholar
• Coenen-Stass AM, Betts CA, Lee YF, et al. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation. Hum Mol Genet. 2016;25(18):3960–3974.
   PubMed Web of Science ®Google Scholar
• Jeanson-Leh L, Lameth J, Krimi S, et al. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in golden retriever muscular dystrophy dogs and duchenne muscular dystrophy patients. Am J Pathol. 2014;184(11):2885–2898.
   PubMed Web of Science ®Google Scholar
• Zaharieva IT, Calissano M, Scoto M, et al. Dystromirs as serum biomarkers for monitoring the disease severity in duchenne muscular Dystrophy. PLoS One. 2013;8(11):e80263.
   PubMed Web of Science ®Google Scholar
• Coenen-Stass AML, Sork H, Gatto S, et al. Comprehensive RNA-sequencing analysis in serum and muscle reveals novel small RNA signatures with biomarker potential for DMD. Mol Ther Nucleic Acids. 2018;13:1–15.
   PubMedGoogle Scholar
• Koutsoulidou A, Photiades M, Kyriakides TC, et al. Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress. Hum Mol Genet. 2017;26(17):3285–3302.
   PubMed Web of Science ®Google Scholar
• Perfetti A, Greco S, Cardani R, et al. Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1. Sci Rep. 2016;6(1):38174.
   PubMedGoogle Scholar
• Meyer D, Dimitriadou E, Hornik K, et al. e1071: Misc functions of the Department of Statistics (e1071). TU Wien. 2014.
   Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140.
   PubMed Web of Science ®Google Scholar
• Kundu S, Aulchenko YS, van Duijn CM, et al. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol. 2011;26(4):261–264.
   PubMed Web of Science ®Google Scholar
• Mi H, Muruganujan A, Ebert D, et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419–D426.
   PubMed Web of Science ®Google Scholar
• Mi H, Muruganujan A, Huang X, et al. Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. 2019;14(3):703–721.
   PubMed Web of Science ®Google Scholar
• Sadik N, Cruz L, Gurtner A, et al. Extracellular RNAs: a new awareness of old perspectives. Methods Mol Biol. 2018;1740:1–15.
   PubMedGoogle Scholar
• Roser AE, Caldi Gomes L, Schünemann J, et al. Circulating miRNAs as diagnostic biomarkers for parkinson’s disease. Front Neurosci. 2018;12:625.
   PubMed Web of Science ®Google Scholar
• Filipow S, Laczmanski L. Blood circulating miRNAs as cancer biomarkers for diagnosis and surgical treatment response. Front Genet. 2019;10:169.
   PubMed Web of Science ®Google Scholar
• Kovanda A, Leonardis L, Zidar J, et al. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep. 2018;8(1):5609.
   PubMedGoogle Scholar
• Masciullo M, Iannaccone E, Bianchi MLE, et al. Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: a clinical and muscle MRI study. Neuromuscul Disord. 2013;23(5):427–431.
   PubMed Web of Science ®Google Scholar
• Li X, Li Y, Zhao L, et al. Circulating muscle-specific miRNAs in duchenne muscular dystrophy patients. Mol Ther Nucleic Acids. 2014;3:e177.
   PubMedGoogle Scholar
• Coenen-Stass AML, Wood MJA, Roberts TC. Biomarker potential of extracellular miRNAs in duchenne muscular dystrophy. Trends Mol Med. 2017;23(11):989–1001.
   PubMed Web of Science ®Google Scholar
• Ayalon G, Davis JQ, Scotland PB, et al. An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell. 2008;135(7):1189–1200.
   PubMed Web of Science ®Google Scholar
• Rouillard AD, Gundersen, GW, Fernandez, NF, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016. https://doi.org/10.1093/database/baw100
   PubMed Web of Science ®Google Scholar
• Arandel L, Espinoza MP, Matloka M, et al. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds. Dis Model Mech. 2017;10(4):487–497.
   PubMed Web of Science ®Google Scholar
• Geng LN, Yao Z, Snider L, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell. 2012;22(1):38–51.
   PubMed Web of Science ®Google Scholar
• Lau EC, Janson MM, Roesler MR, et al. Birth of a healthy infant following preimplantation PKHD1 haplotyping for autosomal recessive polycystic kidney disease using multiple displacement amplification. J Assist Reprod Genet. 2010;27(7):397–407.
   PubMed Web of Science ®Google Scholar
• Gourdon G, Meola G. Myotonic dystrophies: state of the art of new therapeutic developments for the CNS. Front Cell Neurosci. 2017;11:101.
   PubMed Web of Science ®Google Scholar
• Zouvelou V, Rentzos M, Zalonis I, et al. Cognitive impairment and cerebellar atrophy in typical onset 4Q35 fascioscapulohumeral dystrophy. Muscle Nerve. 2008;38(5):1523–1524.
   PubMed Web of Science ®Google Scholar
• Maccaroni K, Balzano E, Mirimao F, et al. Impaired replication timing promotes tissue-specific expression of common fragile sites. Genes (Basel). 2020;11(3):326.
   PubMed Web of Science ®Google Scholar
• Catani M, Dell’acqua F, Thiebaut de Schotten M. A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev. 2013;37(8):1724–1737.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Head SI, Rae C, et al. Brain function in duchenne muscular dystrophy. Brain. 2002;125(Pt 1):4–13.
   PubMedGoogle Scholar
• Hinton VJ, Nereo NE, Fee RJ, et al. Social behavior problems in boys with duchenne muscular dystrophy. J Dev Behav Pediatr. 2006;27(6):470–476.
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120.
   PubMed Web of Science ®Google Scholar
• Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 2017;27(3):491–499.
   PubMed Web of Science ®Google Scholar
• Andrews S FastQC: A Quality Control Tool for High Throughput Sequence Data. 2015. Last accessed 05 07 2021. Available from: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
   Google Scholar
• Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166–169.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Grocock RJ, van Dongen S, et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(90001):D140–4. (Database issue).
   PubMedGoogle Scholar
• Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.
   PubMed Web of Science ®Google Scholar
• Lund SP, Nettleton D, McCarthy DJ, et al. Detecting differential expression in RNA-sequence data using quasi-likelihood with shrunken dispersion estimates. Statistical Applications in Genetics and Molecular Biology. 2012;11(5). DOI:10.1515/1544-6115.1826.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093.
   PubMed Web of Science ®Google Scholar
• Bindea G, Galon J, Mlecnik B. CluePedia cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29(5):661–663.
   PubMed Web of Science ®Google Scholar
• Lipscomb CE. Medical Subject Headings (MeSH). Bull Med Libr Assoc. 2012;88(3):265–6.
   Google Scholar
• Duren W, Weymouth T, Hull T, et al. MetDisease–connecting metabolites to diseases via literature. Bioinformatics. 2014;30(15):2239–2241.
   PubMed Web of Science ®Google Scholar